These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7403155)

  • 1. Effects of octapeptide and heptapeptide angiotensin antagonists in the rat and dog.
    Moore GJ; Taub KJ
    Proc West Pharmacol Soc; 1980; 23():339-43. PubMed ID: 7403155
    [No Abstract]   [Full Text] [Related]  

  • 2. A new class of angiotensin II analogs: substitution of sarcosine in position 7.
    Moore G; Oudeman E; Gorman P
    Proc West Pharmacol Soc; 1978; 21():261-6. PubMed ID: 693506
    [No Abstract]   [Full Text] [Related]  

  • 3. Antagonism of peripheral and central effects of angiotensin II by (1-sarcosine, 8-isoleucine)angiotensin II.
    Sweet CS; Ferrario CM; Khosla MC; Bumpus FM
    J Pharmacol Exp Ther; 1973 Apr; 185(1):35-41. PubMed ID: 4348281
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiotensin II-induced renal prostacyclin release suppresses platelet aggregation in the anesthetized dog.
    Shebuski RJ; Aiken JW
    Adv Prostaglandin Thromboxane Res; 1980; 7():1149-52. PubMed ID: 6989184
    [No Abstract]   [Full Text] [Related]  

  • 5. Heptapeptide analogues induce greater blockade of renal than femoral vascular responses to angiotensin.
    Caldicott WJ; Taub KJ; Korngold E; Hollenberg NK
    Life Sci; 1978 Jul; 23(2):105-10. PubMed ID: 682872
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of angiotensin II antagonist, alpha-receptor blockage, and denervation on blood flow reduction in experimental, chronic hydronephrosis.
    Huland H; Leichtweiss HP; Augustin HJ
    Invest Urol; 1980 Nov; 18(3):203-6. PubMed ID: 6107280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of renal perfusate flow on systemic blood pressure in the rat [proceedings].
    Woodward B
    J Physiol; 1978 Apr; 277():80P. PubMed ID: 650591
    [No Abstract]   [Full Text] [Related]  

  • 8. A carboxy-terminus truncated analogue of angiotensin II, [Sar1]angiotensin II-(1-7)-amide, provides an entry to a new class of angiotensin II antagonists.
    Bovy PR; Trapani AJ; McMahon EG; Palomo M
    J Med Chem; 1989 Mar; 32(3):520-2. PubMed ID: 2918497
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis of angiotensin II antagonists containing sarcosine in position 7.
    Moore GJ; Oudeman EM; Ko D; Nystrom DM
    J Med Chem; 1979 Sep; 22(9):1147-9. PubMed ID: 490564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemistry and mechanism of new angiotensin UU antagonists: 8 C-phenylclycine analogues of [5-isoleucine] angiotensin].
    Wissmann H; Schoelkens B; Lindner E; Geiger R
    Hoppe Seylers Z Physiol Chem; 1974 Sep; 355(9):1083-96. PubMed ID: 4376799
    [No Abstract]   [Full Text] [Related]  

  • 11. Proceedings: Regional renal blood flows in the rat during infusion of natriuretic and anti-natriuretic doeses of angiotensin II.
    Cambridge D; Chapman BJ; Munday KA
    J Endocrinol; 1976 Mar; 68(3):9P-10P. PubMed ID: 1255113
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship between the tooth eruption and regional blood flow in angiotensin II-induced hypertensive rats.
    Shimada A; Shibata T; Komatsu K
    Arch Oral Biol; 2004 Jun; 49(6):427-33. PubMed ID: 15099799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-(1-7) antagonist [D-Ala7-Ang-(1-7);A-779] attenuates post-suspension hypotension in Sprague-Dawley rats.
    Bayorh MA; Wang M; Socci RR; Eatman D; Emmett N; Thierry-Palmer M
    J Gravit Physiol; 1999 Jul; 6(1):P115-6. PubMed ID: 11542983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects after the intracerebroventricular administration of peptide and nonpeptide angiotensin antagonists in Dahl salt-sensitive rats.
    Lark LA; Wappel SM; Weyhenmeyer JA
    J Pharmacol Exp Ther; 1995 Aug; 274(2):745-51. PubMed ID: 7636738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic quotient for some angiotensin antagonists determined from antagonist and agonist activities in rat pressor assays.
    Franklin KJ; Moore GJ
    Proc West Pharmacol Soc; 1987; 30():313-6. PubMed ID: 3628297
    [No Abstract]   [Full Text] [Related]  

  • 16. Intrarenal conversion of angiotensin I to angiotensin II in the dog.
    Di Salvo J; Peterson A; Montefusco C; Menta M
    Circ Res; 1971 Oct; 29(4):398-406. PubMed ID: 4329373
    [No Abstract]   [Full Text] [Related]  

  • 17. Failure of angiotensin II inhibitor to modify hyperacute rejection.
    Haberal MA; Ppovtzer MM; McDonald KM; Guggenheim SJ; Picache RS; Putman CW
    Surgery; 1975 Aug; 78(2):149-53. PubMed ID: 1098189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lyon genetically hypertensive rats: an animal model of "low renin hypertension".
    Sassard J; Lo M; Liu KL
    Acta Pharmacol Sin; 2003 Jan; 24(1):1-6. PubMed ID: 12511223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular neuropeptide Y Y1-receptors in the rat kidney: vasoconstrictor effects and expression of Y1-receptor mRNA.
    Modin A; Malmström RE; Meister B
    Neuropeptides; 1999 Aug; 33(4):253-9. PubMed ID: 10657500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrarenal role of angiotensin II. Homeostatic regulation of renal blood flow in the dog.
    Freeman RH; Davis JO; Vitale SJ; Johnson JA
    Circ Res; 1973 Jun; 32(6):692-8. PubMed ID: 4351766
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.